A detailed history of Geode Capital Management, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Geode Capital Management, LLC holds 7,745,104 shares of ROIV stock, worth $98.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,745,104
Previous 6,284,899 23.23%
Holding current value
$98.4 Million
Previous $66.4 Million 34.54%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.17 - $12.5 $14.9 Million - $18.3 Million
1,460,205 Added 23.23%
7,745,104 $89.4 Million
Q2 2024

Aug 09, 2024

BUY
$10.36 - $11.74 $2.47 Million - $2.79 Million
238,053 Added 3.94%
6,284,899 $66.4 Million
Q1 2024

May 13, 2024

BUY
$9.87 - $11.8 $5.15 Million - $6.16 Million
522,270 Added 9.45%
6,046,846 $63.7 Million
Q4 2023

Feb 13, 2024

BUY
$8.38 - $11.58 $2.57 Million - $3.55 Million
306,396 Added 5.87%
5,524,576 $62 Million
Q3 2023

Nov 13, 2023

BUY
$9.76 - $13.19 $24.2 Million - $32.7 Million
2,478,175 Added 90.44%
5,218,180 $60.9 Million
Q2 2023

Aug 11, 2023

BUY
$7.09 - $10.08 $7.93 Million - $11.3 Million
1,118,562 Added 68.99%
2,740,005 $27.6 Million
Q1 2023

May 15, 2023

BUY
$6.92 - $9.98 $662,590 - $955,585
95,750 Added 6.28%
1,621,443 $12 Million
Q4 2022

Feb 13, 2023

BUY
$3.36 - $7.99 $274,199 - $652,039
81,607 Added 5.65%
1,525,693 $12.2 Million
Q3 2022

Nov 14, 2022

BUY
$0.51 - $4.84 $30,403 - $288,531
59,614 Added 4.31%
1,444,086 $4.65 Million
Q2 2022

Aug 12, 2022

BUY
$2.81 - $4.84 $264,963 - $456,378
94,293 Added 7.31%
1,384,472 $5.63 Million
Q1 2022

May 13, 2022

BUY
$4.74 - $9.91 $616,399 - $1.29 Million
130,042 Added 11.21%
1,290,179 $6.37 Million
Q4 2021

Feb 11, 2022

BUY
$5.86 - $13.52 $6.8 Million - $15.7 Million
1,160,137 New
1,160,137 $11.7 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.95B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.